P-441 Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study

Autor: Sudhini, Yashwanth, Dhakal, Binod, Reiser, Jochen, Altintas, Mehmet, Hahm, Eunsil, Peev, Vasil, Venugopal, Parameswaran, Paner, Agne
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 2:S283-S284
Databáze: ScienceDirect